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A teenage woman migrating from Syria arrived in May 
2015 in Germany. She gave birth to a healthy child in 
early 2016, but became febrile shortly after delivery. 
Blood cultures revealed Brucella melitensis. In retro-
spect, she reported contact with sheep in Syria and 
recurrent pain in the hip joints over about five months 
before diagnosis of brucellosis. We discuss conse-
quences for adequate treatment of mother and child as 
well as for clinical and laboratory management.
As brucellosis is rare in many European countries and 
because there is even less experience with brucellosis 
in association with pregnancy, we here publish a case 
of a young pregnant woman who had migrated from 
Syria to Germany and was diagnosed with brucellosis 
directly after delivery of her child, and illustrate some 
lessons learnt. 
Case report
A teenage female refugee from Syria delivered a full-
term baby (birthweight 3,185 g) with vacuum extrac-
tion in Germany. Because of intrapartum asphyxia, 
mother and child were hospitalised in a special care 
unit. The child recovered without further complications. 
The mother developed a fever of 39 °C on day 1 after 
delivery. Investigation of the mother’s blood revealed 
normal ranges of leukocytes, a slightly decreased 
haemoglobin level and an elevated concentration of 
C-reactive protein (CRP) at 38.0 mg/mL (normal < 5.0 
mg/L). She was treated for three days with intravenous 
ampicillin sulbactam 3 g three times daily and metro-
nidazole 500 mg twice daily. The patient was in good 
clinical condition and discharged from the hospital on 
day 4 with oral sultamicillin 375 mg and metronidazole 
400 mg twice daily.
Two sets of blood cultures (BD Bactec Fx blood cul-
ture system) were taken during pyrexia. One anaerobic 
culture revealed a positive signal after 47 h incuba-
tion that was identified as Fusobacterium nucleatum. 
The aerobic blood culture revealed growth after 117 h 
and Gram staining showed faintly stained small Gram-
negative coccobacilli (Figure 1). Small non-haemolytic 
colonies appeared on Columbia blood agar after 48 
hours incubation at 36 °C in air with 5% CO2 enrich-
ment (Figure 2) and were oxidase-positive. Using 
matrix-assisted laser desorption ionisation time of 
flight (MALDI-TOF) mass spectrometry (MS) (MALDI-
TOF MS, Vitek MS Plus System bioMérieux, research 
use only (RUO) SARAMIS database), Brucella spp. was 
identified and confirmed as Brucella melitensis one day 
later when tested by real-time PCR in a reference labo-
ratory using an accredited in-house assay.
Because of the results of the aerobic blood culture, 
the mother and child were immediately contacted and 
examined on day 11 after delivery. The mother reported 
that she was a sheepherder in Syria before arriving 
in Germany nine months previously and that she had 
suffered from recurrent hip pain for about five months 
before diagnosis of brucellosis. The serum sample 
was tested in parallel with two ELISAs revealing a 
high titre of 1:16,000 (normal: < 1:500; Virion-Serion 
GmbH, Würzburg, Germany) of Brucella-specific anti-
bodies, with IgG of 29.1 U and IgM of 24.3 U (cut-off: 
10 U; Novagnost Brucella IgG and IgM ELISA, Siemens 
Healthcare Diagnostics, Germany). Samples of moth-
er’s milk were not available for laboratory investiga-
tion. The patient was advised to start antibiotic therapy 
with doxycycline 100 mg twice daily and rifampicin 900 
mg once daily for 12 weeks and to stop breastfeeding.
The examination of the baby by the paediatrician 
revealed no relevant clinical or laboratory abnor-
malities. The blood culture set up day 11 after birth 
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remained negative, the serum sample was positive 
only for Brucella-specific IgG antibodies (24.5 U).
In subsequent visits (four and seven weeks after 
delivery), mother and child had no relevant clinical or 
laboratory abnormalities. The antibiotics were well tol-
erated by the mother. Blood cultures from the mother 
drawn in week 7 after delivery remained negative; the 
IgM titre was slightly decreased to 18 U.
After the identification of Brucella spp., two persons 
from the delivery room were monitored and had sero-
logical follow-up. All serological tests at their first visit 
and three months later were negative.
Background
Brucellosis is a zoonosis that occurs worldwide, 
causing great economic losses and a high number 
of human infections in endemic regions, such as the 
Mediterranean, the Middle East including Syria, Iraq, 
Iran and Saudi Arabia, as well as Africa, Asia and 
Middle and South America. It is estimated that more 
than 500,000 people are suffering from brucellosis 
annually [1]. In contrast, only 22 to 47 cases annually 
were reported in Germany between 2010 and 2015. 
Most of these cases were associated with travel to 
endemic countries surrounding the Mediterranean Sea 
(Italy, Spain, Turkey). Between January 2015 and June 
2016, 60 cases of brucellosis in Germany were reported 
to the Robert Koch Institute, 14 from the Middle East 
and North African countries, including four cases from 
Turkey. This seems to point towards a tendency of 
increased importations from these regions. Imported 
brucellosis plays an emergent role in Europe and glob-
ally [2,3].
B. melitensis (goats and sheep) is the most impor-
tant species for human brucellosis, but other species 
like B. abortus (cattle), B. suis biovar 1 (swine) and B. 
canis (dogs) can also be associated with human cases. 
The small Gram-negative coccobacilli are most com-
monly transmitted to humans through contaminated 
food, e.g. unpasteurised milk, or by direct contact 
with infected animals [4,5]. They grow intracellularly, 
e.g. in mononuclear phagocytic cells, cause unspecific 
clinical manifestations especially in the acute stage, 
including typically undulant fever, which may last for 
years if not properly treated. The bacteria can be dis-
seminated to various organs such as liver, spleen, 
bones and joints, genitourinary tract, skin, lung, heart 
and central nervous system. Therefore, human brucel-
losis has a broad variability of clinical signs and can 
mimic other infectious and non-infectious diseases. 
The infection is often diagnosed only when focal com-
plications occur. Symptoms in children and teenagers 
with brucellosis are mostly fever, joint pain and hepa-
tomegaly [6,7]. Intrauterine infections and transmis-
sion of the pathogen through breastfeeding has been 
reported, transmission of antibodies from mother to 
newborn is possible [7].
The laboratory diagnosis is mainly based on classical 
microbiological methods (but isolation could be cum-
bersome and is not always successful), on MALDI-TOF 
MS identification of colonies and on PCR that allows 
the discrimination of Brucella species [8-13]. In addi-
tion, multilocus variable-number tandem repeat analy-
sis and other methods like whole genome sequencing, 
next generation sequencing and single nucleotide pol-
ymorphism analysis allow the generation of molecular 
epidemiology data that can be helpful in the identifi-
cation of outbreak-related strains and the geographi-
cal relation between isolates [14,15]. The detection of 
IgG and IgM antibodies against Brucella antigens in 
serum is a reliable tool for diagnosing human brucel-
losis and classifying the stage of disease [16,17]. IgM 
Figure 2
Bacteria isolated from blood culture forming small non-
haemolytic colonies on Columbia blood agar after 48 
hours incubation at 36 °C air with 5% CO2 enrichment, 
Germany, 2016
Figure 1
Gram staining of bacterial culture showing faintly stained 
small Gram-negative coccobacilli corresponding to 
Brucella spp., Germany, 2016
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anti-Brucella antibodies indicate acute infection, and 
a titre increase in paired serum samples indicates an 
acute or reactivated infection.
Discussion
The accidental cultivation of Brucella melitensis in 
blood cultures drawn during post-partum fever dem-
onstrates the complexity of this diagnosis. The anam-
nestic, clinical and laboratory data of our patient were 
consistent with a protracted or chronic course of bru-
cellosis activated during pregnancy and/or delivery. 
However, the exact point in time and place of infection 
of our patient cannot be determined. As she was work-
ing as sheepherder in her home country before com-
ing to Germany, she may have been infected in Syria, 
but infection along the route of migration is also pos-
sible. Prolonged antimicrobial therapy is imperative 
for achieving cure; monotherapy is associated with a 
high rate of relapse. In this case, the 12-week regimen 
based on oral doxycycline 100 mg twice a day in com-
bination with rifampicin 900 mg/day in a single dose 
was preferred because of its oral application and fewer 
adverse effects compared to the combination of doxy-
cycline with aminoglycosides (such as streptomycin or 
gentamicin).
Because of possible transmission either transpla-
centally or through breastfeeding (during the 11 days 
until diagnosis), the baby was examined. Antibacterial 
treatment was not started for the baby because there 
were no relevant clinical or laboratory abnormalities. 
Regular examinations, at least every three months over 
a period of one year, were advised.
Although person-to-person transmission of brucellosis 
is rare, transmission may occur in contact with con-
taminated blood and by aerosol-producing diagnostic 
procedures [18]. For patients suffering from human 
brucellosis during hospitalisation, standard precau-
tions and contact precautions for those with drain-
ing wounds are required. In the case described here, 
mother and newborn were in a rooming-in unit and 
under contact precautions because of hygiene regula-
tions for refugees.
Handling of cultures with human pathogenic Brucella 
spp. requires biosafety level 3 (BSL3) conditions, i.e. 
consequent work in a class II biologic safety cabinet. 
However, for primary diagnostic samples, accidental 
cultivation of Brucella spp. in a routine (BSL2) labora-
tory cannot be avoided. This entails working without 
safety cabinets for reading agar plates, performing 
phenotypical tests, etc. It was estimated that brucel-
losis represents the most common laboratory-acquired 
infection in clinical routine laboratories [19-21], and an 
enhanced safety policy are necessary to prevent labo-
ratory acquisition of Brucella as well as regular training 
of the laboratory staff to be aware of how to handle and 
cultivate highly pathogenic bacteria such as Brucella 
spp. In our case, technicians had regularly been trained 
to recognise the combination of small faintly stained 
Gram-negative coccobacilli (‘fine sand’), slow-growing 
small colonies on Columbia blood agar and the require-
ment of aerobic conditions with CO2 enrichment, and 
were aware of the necessary biosafety measures. 
When Brucella spp. was suspected during reading of 
the agar plates, handling outside a safety cabinet was 
immediately stopped. All following steps for identifica-
tion were performed under a class II biosafety cabinet 
with adequate precautions; as the risk of infection of 
laboratory personnel was high, we consider that these 
measures were effective in preventing an infection.
Lessons learnt 
The clinical microbiological laboratory plays a key role 
in the diagnosis and management of human brucello-
sis. It should provide a rapid and exact identification of 
every Gram-negative rod that is cultivated from blood 
culture or surgical material to exclude Brucella spp. or 
other highly pathogenic bacteria. Currently, the most 
suitable tool for identification of bacteria is MALDI-
TOF MS because it provides rapid, accurate, sensitive 
and cost-effective identification of human pathogenic 
bacteria. Attention should be paid using commercially 
available MALDI-TOF MS systems including standard 
diagnostic databases to identify Brucella spp. and 
other highly pathogenic bacteria. The related MALDI-
TOF MS databases do not usually support validated 
laboratory diagnoses of highly pathogenic bacteria, 
which should be improved in the future. In addition, 
when highly pathogenic bacteria such as Brucella spp. 
are suspected or the results are ambiguous, material 
should be sent to a reference laboratory for further 
confirmation and identification at species level. When 
sending live material, the international dangerous 
goods regulations for air transportation (International 
Air Transportation Association (IATA)) [22] and ground 
transportation (Accord européen relatif au transport 
international des marchandises Dangereuses par 
Route (ADR)) [23] need to be considered. Alternatively, 
for PCR and genome analyses, sending bacterial DNA 
can be sufficient. Genetic material prepared by an eval-
uated protocol including safe inactivation of the patho-
gen can be sent without considering specific shipment 
regulations.
We can assume that physicians in non-endemic 
European areas have a poor awareness of imported 
brucellosis in patients arriving from regions with 
endemic brucellosis, exemplified in our case by peo-
ple who have migrated from regions in the Middle 
East. Although our patient had been in Germany for 
nine months and in ambulatory care during pregnancy, 
questions on travel history, animal contacts and con-
sumption of raw animal products or duration of symp-
toms were not asked [4,24]. A connection between hip 
pain and brucellosis was not made.
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